Ishita Drugs & Industries has informed that it enclosed Disclosure under regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal.
The above information is a part of company’s filings submitted to BSE.